Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Larry Junck

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Neuro-Oncology|March 22, 2008
Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomasKathleen R Lamborn, W K Alfred Yung, Susan M Chang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 22, 2008
Central nervous system cancersSteven S Brem, Philip J Bierman, Peter Black, et al.
The Lancet. Oncology|September 1, 2023
Combined cytotoxic and immune-stimulatory gene therapy for primary adult high-grade glioma: a phase 1, first-in-human trialYoshie Umemura, Daniel Orringer, Larry Junck, et al.
Antioxidants & Redox Signaling|February 28, 2023
Metabolomic Profiles of Human Glioma Inform Patient SurvivalAndrew J Scott, Luis O Correa, Donna M Edwards, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 6, 2011
Central nervous system cancersSteven S Brem, Philip J Bierman, Henry Brem, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 14, 2013
Central nervous system cancersLouis Burt Nabors, Mario Ammirati, Philip J Bierman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 1, 2005
Central nervous system cancers: Clinical Practice Guidelines in OncologySteven S Brem, Philip J Bierman, Peter Black, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2006
Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08Patrick Y Wen, W K Alfred Yung, Kathleen R Lamborn, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 2, 2014
Central nervous system cancers, version 2.2014. Featured updates to the NCCN GuidelinesLouis Burt Nabors, Jana Portnow, Mario Ammirati, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 5, 2020
Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in OncologyLouis Burt Nabors, Jana Portnow, Manmeet Ahluwalia, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Neuro-Oncology|March 22, 2008
Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomasKathleen R Lamborn, W K Alfred Yung, Susan M Chang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 22, 2008
Central nervous system cancersSteven S Brem, Philip J Bierman, Peter Black, et al.
The Lancet. Oncology|September 1, 2023
Combined cytotoxic and immune-stimulatory gene therapy for primary adult high-grade glioma: a phase 1, first-in-human trialYoshie Umemura, Daniel Orringer, Larry Junck, et al.
Antioxidants & Redox Signaling|February 28, 2023
Metabolomic Profiles of Human Glioma Inform Patient SurvivalAndrew J Scott, Luis O Correa, Donna M Edwards, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 6, 2011
Central nervous system cancersSteven S Brem, Philip J Bierman, Henry Brem, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 14, 2013
Central nervous system cancersLouis Burt Nabors, Mario Ammirati, Philip J Bierman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 1, 2005
Central nervous system cancers: Clinical Practice Guidelines in OncologySteven S Brem, Philip J Bierman, Peter Black, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2006
Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08Patrick Y Wen, W K Alfred Yung, Kathleen R Lamborn, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 2, 2014
Central nervous system cancers, version 2.2014. Featured updates to the NCCN GuidelinesLouis Burt Nabors, Jana Portnow, Mario Ammirati, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 5, 2020
Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in OncologyLouis Burt Nabors, Jana Portnow, Manmeet Ahluwalia, et al.
Pageof 9